NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Activision Blizzard (ATVI) rated new Outperform at Credit Suisse. $16 price target. Company can continue to expand around the globe.
Celgene (CELG) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $86 price target. Company lacks near-term catalysts.
Check Point (CHKP) downgraded at Needham from Buy to Hold, Needham said. Recent field checks suggest that sales could slow down in the coming quarters.Cott Corp (COT) rated new Buy at Citigroup. $10 price target. Strong EPS growth driven by a balance of factors. Chevron (CVX) rated new Hold at Dahlman. Two major LNG projects add risk to the thesis. DR Horton (DHI - Get Report) downgraded at MKM from Buy to Neutral, MKM Partners said. Valuation call, as the sector has already made a big run. Electronic Arts (ERTS) rated new Neutral at Credit Suisse. $16 price target. Company has struggled with its digital transition. FedEx (FDX - Get Report) upgraded at Standpoint from Hold to Buy, Standpoint said. $130 price target. Company is cutting costs and annual earnings can approach $10 a share. Genomic Health (GHDX) rated new Neutral at Goldman. $36 price target. Company has limited earnings upside potential. Host Hotels (HST) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Expect slower industry RevPAR growth. Johnson Controls (JCI) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Management will struggle to turn the company around by 2013. Lennar (LEN) downgraded at MKM from Buy to Neutral, MKM Partners said. See limited upside to near-term earnings expectations. Marriott (MAR) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Stock has outperformed the market year-to-date. MetroPCS Communications (PCS) downgraded at Oppenheimer to Underperform from Perform, Oppenheimer said. Wireless to eventually consolidate into three players. Rite Aid (RAD) rated new Buy at BTIG. $2.25 price target. Company is improving customer retention and margins. Texas Instruments (TXN - Get Report) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $26 price target. Company is leveraged to slower macro growth. Exxon Mobil (XOM - Get Report) rated new Buy at Dahlman. $100 price target. Company will continue to buy back stock in the coming quarters.